According to Saili Medical's announcement, net profit attributable to shareholders of listed companies is expected to be -35 million yuan to -50 million yuan in the semi-year of 2026. Compared with the same period of the previous year, the loss decreased by RMB 61,192 million to a loss of RMB 21.192,000; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses is expected to be -36 million yuan to 51 million yuan. Compared with the same period last year, the loss decreased by 19.5979 million yuan to a loss reduction of RMB 35.5979 million. RMB.

According to Saili Medical's announcement, net profit attributable to shareholders of listed companies is expected to be -35 million yuan to -50 million yuan in the semi-year of 2026. Compared with the same period of the previous year, the loss decreased by RMB 61,192 million to a loss of RMB 21.192,000; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses is expected to be -36 million yuan to 51 million yuan. Compared with the same period last year, the loss decreased by 19.5979 million yuan to a loss reduction of RMB 35.5979 million. RMB.